Related references
Note: Only part of the references are listed.Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19
Reinhold Kreutz et al.
CARDIOVASCULAR RESEARCH (2020)
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19
Peng Zhang et al.
CIRCULATION RESEARCH (2020)
Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension A Single-Center Retrospective Study
Guang Yang et al.
HYPERTENSION (2020)
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy
Graziano Onder et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19
Giuseppe Mancia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Newly recognized components of the renin-angiotensin system: Potential roles in cardiovascular and renal regulation
RM Carey et al.
ENDOCRINE REVIEWS (2003)
Share Paper
